1Division of Cardiology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Dongtan, Korea
2Division of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea
© 2022 Korean Society of Cardiovascular Disease Prevention, Korean Society of Cardiovascular Pharmacotherapy
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ethical statement
Not applicable.
Conflicts of interest
The authors have no conflicts of interest to declare.
Funding
None.
Author contributions
Conceptualization: DYC, SHJ; Data curation: DYC, SHJ; Investigation: DYC, SHJ; Writing–original draft: DYC; Writing-review&editing: SHJ. All authors read and approved the final manuscript.
KSoLA, Korean Society of Lipid and Atherosclerosis; JAS, Japan Atherosclerosis Society; ACC, American College of Cardiology; AHA, American Heart Association; ESC, European Society of Cardiology; EAS, European Atherosclerosis Society; ALT, alanine aminotransferase; T.bil, total bilirubin; AST, aspartate aminotransferase; UNL, upper normal limit; CK, creatinine kinase.